immunoc-oncology
AZ shares climb on positive cancer drug news
September 1, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Pfizer, immunoc-oncology, pd-1
AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
